The reasoning I've heard (and I can't say I disagree with) is that if drug prices in the US weren't market driven, big pharma would have much smaller war chests to work with when it comes to R&D.
As in this case, where Pfizer specifically chose not to take any government support, supposedly because they wanted to avoid any bureaucratic delays.
As in this case, where Pfizer specifically chose not to take any government support, supposedly because they wanted to avoid any bureaucratic delays.